Pfizer Quality Improvement Grant for System-Level Solutions

Deadline: 08-Oct-2026

Pfizer is inviting applications from eligible organizations for quality improvement initiatives that address barriers in the Homologous Recombination Repair mutation (HRRm) testing pathway for metastatic prostate cancer. The grant programme supports practice-based quality improvement projects that implement, evaluate, and scale system-level solutions in both academic and community healthcare settings. The initiative aims to improve the efficiency and reliability of HRRm testing while reducing administrative and operational challenges for clinicians and expanding access for eligible patients.

About the Pfizer Quality Improvement Grant Program

The programme is designed to support formal quality improvement (QI) initiatives focused on improving the HRRm testing pathway for patients with metastatic prostate cancer. Projects should identify important barriers to HRRm testing and develop practical system-level solutions that can be implemented and scaled across healthcare settings. The initiative places particular emphasis on creating efficient, reliable, and standardized processes for HRRm testing. How Much Funding Is Available? Organizations may request up to $100,000 per project. The programme has an estimated total available budget of approximately $200,000.

Funding information includes:

- Maximum project award: $100,000

- Total available budget: Approximately $200,000

- Suggested smaller projects: Requests of around $75,000 are also encouraged

- Maximum project duration: 18 months

- Institutional overhead: Capped at 28%

Award amounts include both direct costs and institutional overhead costs. What Does the Grant Support? The programme supports practice-based quality improvement initiatives that improve the HRRm testing pathway. Projects should focus on implementing and scaling system-level solutions that can address barriers to testing and improve how testing is delivered and used in clinical practice. Supported projects may address one or more high-impact areas.

Priority Area: Improving Sample Quality

Projects may focus on implementing best practices that improve the quality of samples used for HRRm testing. Improving sample quality can help establish more efficient and reliable testing processes and support better continuity throughout the testing pathway.

Priority Area: Multidisciplinary Coordination

Applicants may design and pilot scalable multidisciplinary coordination blueprints. These projects should seek to improve coordination among the professionals and teams involved in HRRm testing and related patient care. The proposed models should have potential for use across both academic and community practice settings.

Priority Area: Reflex Testing Models

Projects may develop and evaluate reflex testing models designed to improve the efficiency and continuity of the HRRm testing process. Applicants should demonstrate how the proposed model can address existing barriers and improve the delivery or utilization of testing in routine practice.

Priority Area: Implementation Science and Technology

The programme also supports projects that apply implementation science and technology-enabled approaches to optimize healthcare workflows. Projects may use workflow optimization and technology to reduce operational or administrative burdens and create more efficient HRRm testing systems. Expected Quality Improvement Outcomes Projects should demonstrate measurable improvements in areas related to the HRRm testing pathway. Potential outcomes include improvements in: - HRRm testing rates. - Testing continuity. - Utilization of test results. - Care coordination. - Efficiency of testing workflows. - Reliability of testing systems. - Standardization of testing processes. Applicants should establish appropriate measures for evaluating the impact of their proposed quality improvement initiative. Academic and Community Practice Settings Projects should have practical relevance to both academic and community practice settings. The programme seeks solutions that can be implemented and scaled beyond a single specialized environment. Applicants should therefore consider how their proposed quality improvement model can be applied across different healthcare practice settings. Who Can Apply? Eligible applicants include organizations working in healthcare, medical education, and professional improvement.

Eligible organizations include:

- Medical professional schools. - Nursing professional schools. - Allied health professional schools. - Pharmacy professional schools. - Healthcare institutions. - Professional organizations. - Medical societies. - Medical education companies. - Other entities with a mission related to healthcare professional education or improvement. Only organizations are eligible to receive grants. Who Is Not Eligible? Individuals are not eligible to receive grants. Unaffiliated medical practice groups are also not eligible. The applicant organization must be able to receive funding directly from Pfizer Inc. Project Requirements Proposed projects must be structured as formal quality improvement initiatives.

Projects should:

- Address barriers in the HRRm testing pathway. - Focus on metastatic prostate cancer. - Implement, evaluate, or scale system-level solutions. - Address one or more of the programme’s priority domains. - Include measurable quality improvement outcomes. - Have relevance to academic and community practice settings. - Demonstrate potential to improve HRRm testing and related care processes. Project Duration The maximum project length is 18 months. Applicants should design a realistic project plan that allows sufficient time to implement the proposed quality improvement intervention, evaluate its results, and demonstrate measurable improvements. Institutional Overhead Costs Grant awards include direct costs and institutional overhead costs. Institutional overhead costs are capped at 28%. Applicants should therefore develop their budgets in accordance with this